Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chronic hepatitis C: common questions, practical answers.

B Gaster1, A Larson

  • 1Department of Medicine, University of Washington, Seattle, USA.

The Journal of the American Board of Family Practice
|September 23, 2000
PubMed
Summary

Hepatitis C virus (HCV) treatment with interferon and ribavirin offers over 30% chance of sustained viral clearance. Primary care physicians are crucial for diagnosing HCV and guiding patients on antiviral therapy risks and benefits.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Search for Double Beta Decays of ^{134}Xe with EXO-200 Phase II.

Physical review letters·2026
Same author

Hypoaminoacidemia and Pyroglutamic Aciduria: Potential Biomarkers in Malnutrition-Related Hyperammonemia.

JIMD reports·2026
Same author

Stability and Cooling of the C_{7}^{2-} Dianion.

Physical review letters·2023
Same author

Measurement of the Spectral Shape of the β-Decay of ^{137}Xe to the Ground State of ^{137}Cs in EXO-200 and Comparison with Theory.

Physical review letters·2020
Same author

Spontaneous Electron Emission from Hot Silver Dimer Anions: Breakdown of the Born-Oppenheimer Approximation.

Physical review letters·2020
Same author

Search for Neutrinoless Double-β Decay with the Complete EXO-200 Dataset.

Physical review letters·2019

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Gastroenterology

Background:

  • Hepatitis C virus (HCV) is a leading cause of chronic liver disease in the U.S.
  • Recent advances include combination therapy with interferon and ribavirin.
  • HCV infection poses a significant public health challenge.

Purpose of the Study:

  • To address common questions faced by primary care physicians regarding chronic HCV infections.
  • To provide evidence-based guidance on HCV diagnosis and management.
  • To inform primary care providers about the utility of antiviral therapies.

Main Methods:

  • Elicited primary care physician questions via email and phone interviews.
  • Conducted computerized literature searches of MEDLINE database.

Related Experiment Videos

  • Consulted expert opinion for comprehensive answers.

    • Main Results:

    • Combination therapy yields >30% chance of normalized transaminase levels and undetectable viral load.
    • Treatment is costly and may have side effects.
    • Long-term impact on liver failure and hepatocellular carcinoma risk is promising but undetermined.

    Conclusions:

    • Primary care physicians are vital for HCV diagnosis and initial patient evaluation.
    • Understanding diagnostic testing and antiviral therapy is key for effective patient screening and counseling.
    • Enhanced provider knowledge improves HCV patient care outcomes.